The name is the button.

An agent writes the code now, and a human thumb hovers over Accept all a hundred times a day. The honest question of this decade is what, exactly, you just accepted. So I read the diff.

Eight years as a backend engineer in Stockholm, back in Tokyo since 2023, and I still ship something small most nights, usually badly. My one rule: the only real review of a model is the thing you built with it. That is why there is no leaderboard on this site.

Around a hundred and forty sources come through — the labs' own posts, the papers, the tools, the runtimes and languages nobody is watching yet, the chip under the demo, and the newsletters people actually forward. What is moving gets counted so the week reads at a glance, and every few days I explain one mechanism in plain words.

A story here is a headline, a short excerpt, one image and the link to whoever wrote it. We never reproduce the post; the images belong to their authors. A post written in Japanese appears in Japanese, exactly as it was published, and the link goes to the original.

— Yuki Halvorsen, Tokyo

← Accept All Archive

Hard Fork (NYT)Voices

What’s the Deal With Billy Evans? A Spoiler-Filled Guide to ‘You Can See Everything’

10.23

This week, we focus on Billy Evans, the breakout character of the documentary “You Can See Everything,” and his Theranos-esque new blood-testing start-up.

Funding & deals

Read at Hard Fork (NYT) ↗

One letter a week, starting soon.

Latest

What’s the Deal With Billy Evans? A Spoiler-Filled Guide to ‘You Can See Everything’

Related

OpenAI lowers valuation target, raises up to $30 billion The Decoder

SiliconChip Industry Week In Review SemiEngineering

AsiaJio Platforms IPO Booked 6.76X On Day 3 So Far, QIB Portion Subscribed 14.18X Inc42

AsiaSK hynix pauses potential $15b US listing of Solidigm Tech in Asia

AsiaMiniMax shares fall below IPO price as AI competition grows Tech in Asia

AsiaCATL-backed Noetix Robotics eyes Hong Kong IPO Tech in Asia